The pursuit of effective and safe vaccines against severe acute respiratory syndrome caused
by SARS-CoV-2 has posed a significant challenge for science in recent years, allowing the …

The development of vaccines is a crucial response against the COVID-19 pandemic and
innovative nanovaccines could increase the potential to address this remarkable challenge …

Gold nanoparticles (AuNPs) decorated with antigens have recently emerged as promising
tools for vaccine development due to their innate ability to provide stability to antigens and …

Introduction: The development of innovative anti-COVID-19 vaccines is a need to ensure the
population's immunity worldwide, with broad protection against variants of concern and low …

An approach to assess severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection (and past infection) was developed. For virus detection, the SARS-CoV-2 virus …

Numerous vaccines have been developed to address the current COVID-19 pandemic, but
safety, cross-neutralizing efficacy, and long-term protectivity of currently approved vaccines …

The coronavirus disease pandemic of 2019 (COVID-19) caused by the novel SARS-CoV-2
coronavirus resulted in economic losses and threatened human health worldwide. The …

The COVID-19 pandemic continues to wreak havoc as worldwide SARS-CoV-2 infection,
hospitalization, and death rates climb unabated. Effective vaccines remain the most …

The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection requires rapid development of vaccines matching the pace of virus mutation. While …

Various vaccine strategies have been proposed in response to the global COVID-19
pandemic, each with unique strategies for eliciting immune responses. Here, we developed …